László Drahos Selected Research

László Drahos Research Topics

Disease

13	Neoplasms (Cancer) 12/2023 - 07/2008
4	Prostatic Neoplasms (Prostate Cancer) 10/2022 - 04/2018
2	Infections 01/2024 - 01/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 05/2022
2	Lung Neoplasms (Lung Cancer) 04/2023 - 05/2022
2	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 02/2012
2	Mitochondrial Diseases (Mitochondrial Disease) 12/2020 - 01/2017
2	Alzheimer Disease (Alzheimer's Disease) 12/2020 - 10/2018
2	Dementia (Dementias) 10/2018 - 05/2018
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 12/2023
1	Adenocarcinoma of Lung 01/2023
1	Hyperplasia 10/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2022
1	Adenocarcinoma 05/2022
1	Large Cell Carcinoma 05/2022
1	Inflammation (Inflammations) 05/2022
1	Rheumatoid Arthritis 05/2022
1	Melanoma (Melanoma, Malignant) 03/2022
1	Carcinoma (Carcinomatosis) 03/2022
1	Kaposi Sarcoma (Kaposi's Sarcoma) 03/2022
1	Sleep Deprivation 02/2022
1	Lactose Intolerance (Intolerance, Lactose) 06/2021
1	Disease Progression 01/2021
1	Migraine Disorders (Migraine) 02/2020
1	Amyloidosis 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2018
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 05/2018
1	Bacterial Infections (Bacterial Infection) 01/2017
1	Fibrosarcoma 01/2017
1	Chronic Disease (Chronic Diseases) 01/2017
1	Schizophrenia (Dementia Praecox) 08/2016
1	Leukemia 02/2012
1	Neuroblastoma 02/2012
1	Breast Neoplasms (Breast Cancer) 02/2012
1	Autoimmune Diseases (Autoimmune Disease) 09/2011
1	Lymphoma (Lymphomas) 07/2008

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2011
4	ProteomeIBA 01/2024 - 10/2018
4	GlycosaminoglycansIBA 04/2023 - 05/2022
4	Heparitin Sulfate (Heparan Sulfate)IBA 04/2023 - 05/2022
4	Chondroitin Sulfates (Chondroitin Sulfate)IBA 04/2023 - 05/2022
3	DisaccharidesIBA 04/2023 - 04/2018
3	Glycoproteins (Glycoprotein)IBA 01/2021 - 07/2008
2	ParaffinIBA 04/2023 - 05/2022
2	Formaldehyde (Formol)FDA Link 04/2023 - 05/2022
2	Polysaccharides (Glycans)IBA 05/2022 - 07/2008
2	Complement System Proteins (Complement)IBA 12/2020 - 12/2018
2	Amyloid (Amyloid Fibrils)IBA 01/2019 - 10/2018
1	phenylphosphonic acidIBA 12/2023
1	OxidesIBA 12/2023
1	Organophosphonates (Phosphonates)IBA 12/2023
1	EnzymesIBA 04/2023
1	MucinsIBA 01/2023
1	serum P-component (CIt)IBA 07/2022
1	Immunoglobulin G (IgG)IBA 05/2022
1	GlycopeptidesIBA 05/2022
1	acetyl 4-aminosalicylic acidIBA 05/2022
1	Anti-Citrullinated Protein AntibodiesIBA 05/2022
1	TrypsinIBA 05/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2022
1	Cytostatic AgentsIBA 03/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	GalactosidasesIBA 06/2021
1	SeptinsIBA 12/2020
1	Serotonin (5 Hydroxytryptamine)IBA 02/2020
1	SugarsIBA 10/2019
1	Mannose (D-Mannose)IBA 10/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Serum Amyloid P-ComponentIBA 01/2019
1	Keratins (Keratin)IBA 01/2019
1	Prealbumin (Transthyretin)IBA 01/2019
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2019
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2017
1	alpha-hydroxyglutarateIBA 01/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2017
1	Sirolimus (Rapamycin)FDA Link 01/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2017
1	Blood Proteins (Serum Proteins)IBA 01/2016
1	thiazolyl blueIBA 02/2012
1	AminesIBA 02/2012
1	ferroceneIBA 02/2012
1	AutoantigensIBA 09/2011
1	AcidsIBA 02/2009
1	OligosaccharidesIBA 07/2008
1	Orosomucoid (Seromucoid)IBA 07/2008

Therapy/Procedure

1	Precision Medicine 01/2017
1	Radiotherapy 01/2016